Literature DB >> 12872198

Application of endoscopy for a midbrain tumor.

T Nishikawa1, Y Kang, T Lee, N Takehira, S Waga.   

Abstract

OBJECTIVE AND IMPORTANCE: It has been difficult to obtain a biopsy of a midbrain lesion. In addition, proper cerebrospinal fluid diversion should be secured because progressing tumor in the midbrain causes obstructive hydrocephalus. We report on the superiority of flexible neuroendoscopy to treat progressing midbrain tumor. CLINICAL
PRESENTATION: A 64-year-old man presented with an occasional double vision. A magnetic resonance imaging scan disclosed an enhancing lesion in the midbrain. INTERVENTION: We performed a neuroendoscopic biopsy of the tumor and third ventriculostomy. Neuroendoscopy confirmed a bulging of the posterior commissure, which caused stenosis of the entrance of the aqueduct. Histological examination of the specimen obtained disclosed a diffuse astrocytoma. No permanent postoperative complications occurred although the patient felt slight double vision for 2 days after the operation. Conventional radiation therapy was supplemented.
CONCLUSION: Flexible neuroendoscopic biopsy with third ventriculostomy was a less-invasive and safer alternative for the progressing midbrain tumor bulging into the ventricles.

Entities:  

Mesh:

Year:  2003        PMID: 12872198     DOI: 10.1055/s-2003-40735

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  2 in total

1.  Neuronavigational neuroendoscopic surgery. Frameless free-hand maneuvering of a handy rigid-rod neuroendoscope on visualized three-dimensional computerized image guidance: trajectory to the prepontine cistern in cadaver study.

Authors:  Yuichiro Nonaka; Shizuo Oi; Amir Samii; Vincenzo Paterno; Günther C Feigl; Wolf Lüdemann; Madjid Samii
Journal:  Childs Nerv Syst       Date:  2005-08-10       Impact factor: 1.475

2.  Primary midbrain cystic germinoma mimicking glioma: a case with neuroendoscopic biopsy.

Authors:  Masafumi Uchino; Daisuke Haga; Toshiaki Mito; Tohru Kuramitsu; Noriko Nakamura
Journal:  J Neurooncol       Date:  2006-03-24       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.